SPDL1 and neoplasm: Future studies should try to evaluate the role of sPD-L1 and other soluble immune checkpoint-related proteins to elucidate their role as intrinsic tumor markers with utility in prognostic evaluation involving CCRCC as a malignancy without markers of clinical value, despite the great therapeutic success that has been achieved in the last decade.